MTA3
Basic information
Region (hg38): 2:42494569-42756947
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTA3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in MTA3
This is a list of pathogenic ClinVar variants found in the MTA3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-42568765-G-T | not specified | Uncertain significance (Oct 03, 2022) | ||
2-42579177-T-C | not specified | Uncertain significance (Oct 22, 2021) | ||
2-42609464-T-C | not specified | Uncertain significance (Mar 13, 2023) | ||
2-42609470-A-C | not specified | Uncertain significance (Oct 27, 2023) | ||
2-42640216-T-G | not specified | Uncertain significance (Feb 07, 2023) | ||
2-42644131-C-A | not specified | Uncertain significance (Oct 11, 2024) | ||
2-42644157-C-G | not specified | Uncertain significance (Feb 26, 2024) | ||
2-42644226-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
2-42644233-T-C | not specified | Uncertain significance (Feb 05, 2024) | ||
2-42656214-A-G | not specified | Uncertain significance (Apr 16, 2024) | ||
2-42656235-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
2-42656241-G-A | not specified | Uncertain significance (Aug 27, 2024) | ||
2-42656301-C-T | not specified | Uncertain significance (Oct 24, 2024) | ||
2-42659795-G-A | Short stature | Likely pathogenic (Nov 18, 2001) | ||
2-42682488-T-C | not specified | Uncertain significance (May 06, 2024) | ||
2-42682498-A-T | not specified | Uncertain significance (Nov 14, 2024) | ||
2-42704212-C-G | not specified | Uncertain significance (Oct 13, 2023) | ||
2-42704218-A-G | not specified | Uncertain significance (Aug 21, 2023) | ||
2-42704285-C-T | not specified | Uncertain significance (May 26, 2024) | ||
2-42704289-T-G | not specified | Uncertain significance (Apr 11, 2023) | ||
2-42707945-T-C | not specified | Uncertain significance (Apr 08, 2022) | ||
2-42708026-A-G | not specified | Uncertain significance (Aug 26, 2024) | ||
2-42708916-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
2-42708941-G-A | not specified | Uncertain significance (May 24, 2024) | ||
2-42708964-C-T | not specified | Uncertain significance (Aug 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTA3 | protein_coding | protein_coding | ENST00000407270 | 14 | 262379 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0343 | 0.966 | 124629 | 0 | 8 | 124637 | 0.0000321 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.658 | 233 | 263 | 0.886 | 0.0000141 | 3342 |
Missense in Polyphen | 43 | 81.174 | 0.52973 | 1042 | ||
Synonymous | -1.78 | 114 | 92.2 | 1.24 | 0.00000489 | 935 |
Loss of Function | 3.49 | 8 | 27.9 | 0.287 | 0.00000133 | 394 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000994 | 0.0000994 |
East Asian | 0.0000570 | 0.0000556 |
Finnish | 0.0000476 | 0.0000464 |
European (Non-Finnish) | 0.0000360 | 0.0000354 |
Middle Eastern | 0.0000570 | 0.0000556 |
South Asian | 0.0000339 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in maintenance of the normal epithelial architecture through the repression of SNAI1 transcription in a histone deacetylase-dependent manner, and thus the regulation of E-cadherin levels. Contributes to transcriptional repression by BCL6. {ECO:0000269|PubMed:12705869, ECO:0000269|PubMed:15454082}.;
- Pathway
- Preimplantation Embryo;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Positive epigenetic regulation of rRNA expression;Signal Transduction;Epigenetic regulation of gene expression;Gene expression (Transcription);downregulated of mta-3 in er-negative breast tumors;HDACs deacetylate histones;RNA Polymerase I Promoter Clearance;Chromatin modifying enzymes;RNA Polymerase I Transcription;RNA Polymerase I Transcription Initiation;Regulation of PTEN gene transcription;PTEN Regulation;PIP3 activates AKT signaling;Chromatin organization;Intracellular signaling by second messengers
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.290
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 17.91
Haploinsufficiency Scores
- pHI
- 0.830
- hipred
- Y
- hipred_score
- 0.814
- ghis
- 0.610
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mta3
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- mta3
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- absent
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;positive regulation of cell population proliferation;positive regulation of G2/M transition of mitotic cell cycle;histone deacetylation;negative regulation of transcription, DNA-templated;positive regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;nucleoplasm;cytoplasm;NuRD complex;intracellular membrane-bounded organelle
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II repressing transcription factor binding;chromatin binding;transcription coactivator activity;transcription corepressor activity;histone deacetylase activity;protein binding;zinc ion binding;histone deacetylase binding;sequence-specific DNA binding;protein-containing complex binding